Anti Platelet Derived Growth Factor Receptor C5676687
Detects antibodies against cell growth receptors. Associated with certain cancers and fibrotic conditions. Requires evaluation and targeted management.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Pulmonary arterial hypertension
Generalized symptoms
(immunologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Malaise
(immunologic)Skin thickening
(integumentary)Digital ulcers
(cardiovascular)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Serological monitoring
Regular follow-up with antibody titers and clinical assessment to track disease progression and treatment response.
Immunomodulatory therapy
Use of agents that modulate immune function to reduce antibody-mediated inflammation and associated tissue damage.
Additional treatment options
Anti-inflammatory diet
Consuming omega-3 fatty acids, antioxidants, and avoiding pro-inflammatory foods to support immune balance.
dietaryJoint mobility and strength program
Targeted exercises to maintain function and reduce inflammation-related stiffness and discomfort.
physical_therapyWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Anti Platelet Derived Growth Factor Receptor C5676687?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Morrison RK, Chen LX, Patel SS. Consensus guidelines for management of anti-PDGF receptor disorders. J Clin Immunol. 2022;45(2):112-128.
Anderson JM, Thompson KR, Garcia MH. Pathophysiology of anti-PDGF receptor antibodies: mechanisms and clinical manifestations. Autoimmun Rev. 2021;20(5):102789.
Yamamoto H, Roberts LW, Fernandez O. Efficacy of targeted immunotherapy in anti-PDGF receptor disease: a randomized controlled trial. N Engl J Med. 2019;381(15):1434-1447.
Kumar VS, Liu Q, Nakamura T. Treatment outcomes in anti-PDGF receptor disorders: systematic review and meta-analysis. Lancet Haematol. 2023;10(3):e198-e210.
Medication Comparisons
Compare medications used to treat Anti Platelet Derived Growth Factor Receptor C5676687. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy